LivaNova PLC
LivaNova PLC (LIVN) Covered Calls
As of September 30, 2026, LIVN has 27 covered call opportunities in the coming three months. Return ranges from 1.0 to 36.2% until expiration. Annualized return ranges from 18.4 to 78.1%. The nearest expiration is October 16, 2026. Maximum potential profit is $2,794.
Read more
Running LIVN covered calls helps you generate consistent income from LivaNova PLC's shares you already own, turning a long stock position into a yield-producing asset. A covered call on LivaNova PLC involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best LIVN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if LIVN stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling LIVN covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given LivaNova PLC covered call is worth writing.
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea.
It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Income-focused investors, long-term LIVN holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling LIVN covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best LivaNova PLC covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile47.22% Neutral
- Market cap (M$)4,215
- 52 weeks high-10.80%
- 52 weeks low56.70%
- Analyst recommendationBuy
1.64 - Target price$90.67
20.52% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E22.70
- Future P/E16.36
- EPS (ttm)3.37
- EPS growth next 5 years10.25%
As of September 30, 2026
| 2026-12-18 | 81 | 90.00 | 16.57 | 0.60 | 2.45 | 1339.00 | 17.34 | 78.15 | -0.78 | +0.22 | 37 | 1.85 |
| 2026-11-20 | 53 | 85.00 | 10.09 | 0.45 | 3.70 | 824.00 | 10.67 | 73.50 | -0.58 | +0.30 | 0 | 3.25 |
| 2027-01-15 | 109 | 92.50 | 19.80 | 0.05 | 3.50 | 1534.00 | 19.87 | 66.53 | -0.06 | +0.22 | 0 | 3.45 |
| 2027-04-16 | 200 | 105.00 | 35.99 | 0.15 | 3.50 | 2794.00 | 36.19 | 66.04 | -0.19 | +0.18 | 0 | 3.35 |
| 2026-12-18 | 81 | 87.50 | 13.33 | 0.40 | 3.70 | 1069.00 | 13.85 | 62.39 | -0.52 | +0.28 | 0 | 3.30 |
| 2026-11-20 | 53 | 82.50 | 6.85 | 1.30 | 4.30 | 659.00 | 8.54 | 58.78 | -1.68 | +0.37 | 0 | 3.00 |
| 2027-01-15 | 109 | 90.00 | 16.57 | 0.05 | 3.90 | 1284.00 | 16.63 | 55.69 | -0.06 | +0.25 | 2 | 3.85 |
| 2027-04-16 | 200 | 100.00 | 29.52 | 0.75 | 3.90 | 2354.00 | 30.49 | 55.64 | -0.97 | +0.22 | 0 | 3.15 |
| 2026-12-18 | 81 | 85.00 | 10.09 | 1.20 | 3.80 | 899.00 | 11.64 | 52.47 | -1.55 | +0.33 | 2 | 2.60 |
| 2027-01-15 | 109 | 87.50 | 13.33 | 0.50 | 4.30 | 1079.00 | 13.97 | 46.80 | -0.65 | +0.30 | 3 | 3.80 |
As of September 30, 2026
Sell covered calls with the data behind you
Find the best LIVN covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→